- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 10-K Annual report
- 3.1 Composite Articles of Incorporation
- 3.2 Composite Marked Articles of Incorporation
- 4.3 Description of Securities
- 10.8 Summary of Directors Ongoing Compensation
- 10.18 Stock Option Agreement
- 10.19 Restricted Stock Agreement
- 10.20 Restricted Stock Agreement for Israelis
- 23.1 Consent of Kost Forer Gabbay & Kasierer, a Member of Ernst & Young Global
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-218916) and in the Registration Statements on Form S-8 (Registration No. 333-229535, 333-222888, 333-217770, 333-212299, 333-206848, 333-196537, 333-173777 and 333-162577) pertaining to the Amended and Restated 2005 Stock Option Plan and the 2016 Equity Compensation Plan of Pluristem Therapeutics Inc. of our reports dated September 12, 2019, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., and the effectiveness of internal control over financial reporting of Pluristem Therapeutics Inc., included in this Annual Report (Form 10-K) for the year ended June 30, 2019.
/s/ Kost Forer Gabbay & Kasierer | ||
Haifa, Israel | Kost Forer Gabbay & Kasierer | |
September 12, 2019 | A Member of Ernst & Young Global |